Development of Rho-kinase inhibitors for cardiovascular medicine

被引：0
|
作者：
Shimokawa, Hiroaki [1 ]
机构：
[1] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Aoba Ku, Sendai, Miyagi 9808574, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2009年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：37P / 37P
页数：1
相关论文
共 50 条
  • [1] Development of Rho-kinase inhibitors for cardiovascular medicine
    Shimokawa, Hiroaki
    Rashid, Mamunur
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2007, 28 (06) : 296 - 302
  • [2] Rho-Kinase Inhibitors for Cardiovascular Disease
    Stavenger, Robert A.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 43, 2008, 43 : 87 - 102
  • [3] Rho-Kinase is an important therapeutic target in cardiovascular medicine
    Shimokawa, Hiroaki
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 25 - 26
  • [4] Rho-kinase is an important therapeutic target in cardiovascular medicine
    Shimokawa, H
    Takeshita, A
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (09) : 1767 - 1775
  • [5] Therapeutic potential of Rho-kinase inhibitors in cardiovascular diseases
    Hirooka Y.
    Shimokawa H.
    American Journal of Cardiovascular Drugs, 2005, 5 (1) : 31 - 39
  • [6] RHO-KINASE IS AN IMPORTANT THERAPEUTIC TARGET IN CARDIOVASCULAR MEDICINE
    Shimokawa, H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [7] Translational research for the development of Rho-kinase inhibitors
    Shimokawa, Hiroaki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 18P - 18P
  • [8] Development of specific Rho-kinase inhibitors and their clinical application
    Tamura, M
    Nakao, H
    Yoshizaki, H
    Shiratsuchi, M
    Shigyo, H
    Yamada, H
    Ozawa, T
    Totsuka, J
    Hidaka, H
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2005, 1754 (1-2): : 245 - 252
  • [9] Advances in the studies of roles of Rho/Rho-kinase in diseases and the development of its inhibitors
    Guan, Ronggui
    Xu, Xiaoyu
    Chen, Meihui
    Hu, Haiyan
    Ge, Hu
    Wen, Shijun
    Zhou, Shiyou
    Pi, Rongbiao
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 70 : 613 - 622
  • [10] Development of dihydropyridone indazole amides as selective Rho-kinase inhibitors
    Goodman, Krista B.
    Cui, Haifeng
    Dowdell, Sarah E.
    Gaitanopoulos, Dimitri E.
    Ivy, Robert L.
    Sehon, Clark A.
    Stavenger, Robert A.
    Wang, Gren Z.
    Viet, Andrew Q.
    Xu, Weiwei
    Ye, Guosen
    Semus, Simon F.
    Evans, Christopher
    Fries, Harvey E.
    Jolivette, Larry J.
    Kirkpatrick, Robert B.
    Dul, Edward
    Khandekar, Sanjay S.
    Yi, Tracey
    Jung, David K.
    Wright, Lois L.
    Smith, Gary K.
    Behm, David J.
    Bentley, Ross
    Doe, Christopher P.
    Hu, Erding
    Lee, Dennis
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (01) : 6 - 9
12345